Cutting Edge: The Human CytomegalovirusUL40Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis
Author(s) -
Matthias Ulbrecht,
Silvia Martinozzi,
Mariola Grzeschik,
Hartmut Hengel,
Joachim W. Ellwart,
Marika Pla,
Elisabeth H. Weiss
Publication year - 2000
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.164.10.5019
Subject(s) - human leukocyte antigen , mhc class i , biology , major histocompatibility complex , ligand (biochemistry) , microbiology and biotechnology , gene , antigen presentation , human cytomegalovirus , immune system , receptor , t cell , antigen , immunology , genetics
Human CMV has evolved multiple strategies to interfere with immune recognition of the host. A variety of mechanisms target Ag presentation by MHC class I molecules resulting in a reduced class I cell-surface expression. This down-regulation of class I molecules is expected to trigger NK cytotoxicity, which would have to be counteracted by the virus to establish long-term infection. Here we describe that the human CMV open reading frame UL40 encodes a canonical ligand for HLA-E, identical with the HLA-Cw03 signal sequence-derived peptide. Expression of UL40 in HLA-E-positive target cells conferred resistance to NK cell lysis via the CD94/NKG2A receptor. Generation of the UL40-derived HLA-E ligand was also observed in TAP-deficient cells. The presence of a functional TAP-independent HLA-E ligand in the UL40 signal sequence implicates this viral gene as an important negative regulator of NK activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom